Skip to main content
Top
Published in: Malaria Journal 1/2008

Open Access 01-12-2008 | Methodology

Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies

Authors: Elke S Bergmann-Leitner, Ryan M Mease, Elizabeth H Duncan, Farhat Khan, John Waitumbi, Evelina Angov

Published in: Malaria Journal | Issue 1/2008

Login to get access

Abstract

Background

Antibodies are the main effectors against malaria blood-stage parasites. Evaluation of functional activities in immune sera from Phase 2a/b vaccine trials may provide invaluable information in the search for immune correlates of protection. However, the presence of anti-malarial-drugs, improper collection/storage conditions or concomitant immune responses against other pathogens can contribute to non-specific anti-parasite activities when the sera/plasma are tested in vitro. Purification of immunoglobulin is a standard approach for reducing such non-specific background activities, but the purification method itself can alter the quality and yield of recovered Ag-specific antibodies.

Methods

To address this concern, various immunoglobulin (Ig) purification methods (protein G Sepharose, protein A/G Sepharose, polyethylene glycol and caprylic acid-ammonium sulphate precipitation) were evaluated for their impact on the quality, quantity and functional activity of purified rabbit and human Igs. The recovered Igs were analysed for yield and purity by SDS-PAGE, for quality by Ag-specific ELISAs (determining changes in titer, avidity and isotype distribution) and for functional activity by in vitro parasite growth inhibition assay (GIA).

Results

This comparison demonstrated that overall polyethylene glycol purification of human serum/plasma samples and protein G Sepharose purification of rabbit sera are optimal for recovering functional Ag-specific antibodies.

Conclusion

Consequently, critical consideration of the purification method is required to avoid selecting non-representative populations of recovered Ig, which could influence interpretations of vaccine efficacy, or affect the search for immune correlates of protection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Buchacher A, Iberer G: Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety. Biotechnol J. 2006, 1: 148-163.CrossRefPubMed Buchacher A, Iberer G: Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety. Biotechnol J. 2006, 1: 148-163.CrossRefPubMed
2.
go back to reference Chang CE, Eo HG, Lee YS, Chung SK, Shin JS, Lah YK, Park CW, Jung JT, Huh JW, Lee SM: Human intravenous immunoglobulin preparation and virus inactivation by pasteurization and solvent detergent treatment. Prep Biochem Biotechnol. 2000, 30: 177-197.CrossRefPubMed Chang CE, Eo HG, Lee YS, Chung SK, Shin JS, Lah YK, Park CW, Jung JT, Huh JW, Lee SM: Human intravenous immunoglobulin preparation and virus inactivation by pasteurization and solvent detergent treatment. Prep Biochem Biotechnol. 2000, 30: 177-197.CrossRefPubMed
3.
go back to reference Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA: Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titers and in vitro parasite-inhibitory activity. Infect Immun. 2006, 74: 4573-80.PubMedCentralCrossRefPubMed Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA: Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titers and in vitro parasite-inhibitory activity. Infect Immun. 2006, 74: 4573-80.PubMedCentralCrossRefPubMed
4.
go back to reference Parkkinen J, Rahola A, von Bonsdorff L, Tolo H, Torma E: A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance. Vox Sang. 2006, 90: 97-104.CrossRefPubMed Parkkinen J, Rahola A, von Bonsdorff L, Tolo H, Torma E: A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance. Vox Sang. 2006, 90: 97-104.CrossRefPubMed
5.
go back to reference Turpin EA, Lauer DC, Swayne DE: Development and evaluation of a blocking enzyme-linked immunosorbent assay for detection of avian metapneumovirus type C-specific antibodies in multiple domestic avian species. J Clin Microbiol. 2003, 41: 3579-3583.PubMedCentralCrossRefPubMed Turpin EA, Lauer DC, Swayne DE: Development and evaluation of a blocking enzyme-linked immunosorbent assay for detection of avian metapneumovirus type C-specific antibodies in multiple domestic avian species. J Clin Microbiol. 2003, 41: 3579-3583.PubMedCentralCrossRefPubMed
6.
go back to reference Temponi M, Kageshita T, Perosa F, Ono R, Okada H, Ferrone S: Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma. 1989, 8: 85-95.CrossRefPubMed Temponi M, Kageshita T, Perosa F, Ono R, Okada H, Ferrone S: Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma. 1989, 8: 85-95.CrossRefPubMed
7.
go back to reference Eliasson M, Olsson A, Palmcrantz E, Wiberg K, Inganäs M, Guss B, Lindberg M, Uhlén M: Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem. 1988, 263: 4323-4327.PubMed Eliasson M, Olsson A, Palmcrantz E, Wiberg K, Inganäs M, Guss B, Lindberg M, Uhlén M: Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem. 1988, 263: 4323-4327.PubMed
8.
go back to reference Bjorck L, Kronvall G: Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol. 1984, 133: 969-974.PubMed Bjorck L, Kronvall G: Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol. 1984, 133: 969-974.PubMed
9.
go back to reference Russ C, Callegaro I, Lanza B, Ferrone S: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Meth. 1983, 65: 269-271.CrossRef Russ C, Callegaro I, Lanza B, Ferrone S: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Meth. 1983, 65: 269-271.CrossRef
10.
go back to reference Roque ACA, Silva CSO, Taipa MA: Affinity-based methodologies and ligands for antibody purification: Advances and perspectives. J Chromatogr A. 2007, 1160: 44-55.CrossRefPubMed Roque ACA, Silva CSO, Taipa MA: Affinity-based methodologies and ligands for antibody purification: Advances and perspectives. J Chromatogr A. 2007, 1160: 44-55.CrossRefPubMed
11.
go back to reference Azevedo AM, Rosa PA, Ferreira IF, Aires-Barros MR: Optimisation of aqueous two-phase extraction of human antibodies. J Biotechnol. 2007, 132: 209-217.CrossRefPubMed Azevedo AM, Rosa PA, Ferreira IF, Aires-Barros MR: Optimisation of aqueous two-phase extraction of human antibodies. J Biotechnol. 2007, 132: 209-217.CrossRefPubMed
12.
go back to reference Wilson S, Booth M, Jones FM, Mwatha JK, Kimani G, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW: Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection. BMC Infect Dis. 2007, 7: 67-PubMedCentralCrossRefPubMed Wilson S, Booth M, Jones FM, Mwatha JK, Kimani G, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW: Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection. BMC Infect Dis. 2007, 7: 67-PubMedCentralCrossRefPubMed
13.
go back to reference Verhofstede C, Van Gelder P, Rabaey M: The infection-stage-related IgG response to Toxoplasma gondii studied by immunoblotting. Parasitol Res. 1988, 74: 516-520.CrossRefPubMed Verhofstede C, Van Gelder P, Rabaey M: The infection-stage-related IgG response to Toxoplasma gondii studied by immunoblotting. Parasitol Res. 1988, 74: 516-520.CrossRefPubMed
14.
go back to reference Morgan J, Dias JC, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR: Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg. 1996, 55: 355-359.PubMed Morgan J, Dias JC, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR: Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg. 1996, 55: 355-359.PubMed
15.
go back to reference Soe S, Theisen M, Rouissilhon C, Aye KS, Druilhe P: Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect Immun. 2004, 72: 247-252.PubMedCentralCrossRefPubMed Soe S, Theisen M, Rouissilhon C, Aye KS, Druilhe P: Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect Immun. 2004, 72: 247-252.PubMedCentralCrossRefPubMed
16.
go back to reference Rouissilhon C, Ouevray C, Mueller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Perignon JL, Druilhe P: Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 2007, 4: e320-CrossRef Rouissilhon C, Ouevray C, Mueller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Perignon JL, Druilhe P: Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 2007, 4: e320-CrossRef
17.
go back to reference Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, Druilhe P: A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol. 2007, 178: 3099-3106.CrossRefPubMed Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, Druilhe P: A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol. 2007, 178: 3099-3106.CrossRefPubMed
18.
go back to reference Tebo AE, Kremsner PG, Luty AJ: Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp Parasitol. 2001, 98: 20-28.CrossRefPubMed Tebo AE, Kremsner PG, Luty AJ: Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp Parasitol. 2001, 98: 20-28.CrossRefPubMed
19.
go back to reference Frank MB: Antibody binding to Protein A and Protein G beads. Molecular Biology Protocols, Oklahoma City. Edited by: Frank MB. 2001 Frank MB: Antibody binding to Protein A and Protein G beads. Molecular Biology Protocols, Oklahoma City. Edited by: Frank MB. 2001
20.
go back to reference Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA: The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect Immun. 2005, 73: 287-297.PubMedCentralCrossRefPubMed Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA: The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect Immun. 2005, 73: 287-297.PubMedCentralCrossRefPubMed
21.
go back to reference Lyon JA, Carter JM, Thomas AW, Chulay JD: Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal. Mol Biochem Parasitol. 1997, 90: 223-234.CrossRefPubMed Lyon JA, Carter JM, Thomas AW, Chulay JD: Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal. Mol Biochem Parasitol. 1997, 90: 223-234.CrossRefPubMed
22.
go back to reference Perosa F, Carbone R, Ferrone S, Dammacco F: Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods. 1990, 128: 9-16.CrossRefPubMed Perosa F, Carbone R, Ferrone S, Dammacco F: Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods. 1990, 128: 9-16.CrossRefPubMed
23.
go back to reference Pullen GR, Fitzgerald MG, Hosking CS: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods. 1986, 86: 83-87.CrossRefPubMed Pullen GR, Fitzgerald MG, Hosking CS: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods. 1986, 86: 83-87.CrossRefPubMed
24.
go back to reference Bergmann-Leitner ES, Scheiblhofer S, Weiss R, Duncan EH, Leitner WW, Chen D, Angov E, Khan F, Williams JL, Winter DB, Thalhamer J, Lyon JA, Tsokos GC: C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. Int Immunol. 2005, 17: 245-255.CrossRefPubMed Bergmann-Leitner ES, Scheiblhofer S, Weiss R, Duncan EH, Leitner WW, Chen D, Angov E, Khan F, Williams JL, Winter DB, Thalhamer J, Lyon JA, Tsokos GC: C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. Int Immunol. 2005, 17: 245-255.CrossRefPubMed
25.
go back to reference Bergmann-Leitner ES, Duncan EH, Burge JR, Spring M, Angov E: Short report: Miniaturization of a high-hroughput pLDH-based Plasmodium falciparum growth inhibition assay for small volume samples from preclinical and clinical vaccine trials. Am J Trop Med Hyg. 2008, 78: Bergmann-Leitner ES, Duncan EH, Burge JR, Spring M, Angov E: Short report: Miniaturization of a high-hroughput pLDH-based Plasmodium falciparum growth inhibition assay for small volume samples from preclinical and clinical vaccine trials. Am J Trop Med Hyg. 2008, 78:
26.
Metadata
Title
Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies
Authors
Elke S Bergmann-Leitner
Ryan M Mease
Elizabeth H Duncan
Farhat Khan
John Waitumbi
Evelina Angov
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2008
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-7-129

Other articles of this Issue 1/2008

Malaria Journal 1/2008 Go to the issue